Hong Kong Stock Market Closes (07.29) | Hang Seng Index Down 0.15% Pharmaceutical Stocks Lead Again
Zhitong Caijing APP has learned that Hong Kong stocks opened low and continued to fall, with all three major indexes plummeting over 1% at one point before narrowing their losses by the close. As of the close, the Hang Seng Index fell 0.15%, or 37.68 points, to 25524.45; the Hang Seng China Enterprises Index fell 0.34%, to 9145.92; and the Hang Seng Technology Index fell 0.35%, to 5644.38.
Shenyin Wanguo Securities believes that recent domestic mid-to-long-term reform policies have accelerated, with supply-side policies (represented by anti-inflationary measures) and demand-side policies (represented by pro-natal policies) working together to effectively improve macroeconomic indicators and boost investor confidence. This will continue to boost the Hong Kong stock market, which is poised for a potential bull run.
Blue-Chip Stocks Performance
Pharmaceutical stocks led the charge again. As of the close, Pharmaniq (02359) rose 11.25%, to HK$111.7; Taike Pharmaceuticals (03347) rose 9.64%, to HK$58.6; Showtime Pharmaceutical (06127) rose 7.29%, to HK$27.95; and Kanglong Chemical (03759) rose 6.4%, to HK$24.95.
Pharmaniq released its interim report for the first half of 2025, with revenue reaching RMB207.99 billion, up 20.6% year-on-year. The company also announced that it would raise its full-year guidance, expecting a growth rate of 13-17% and full-year revenue of RMB425-435 billion.
Guotai Junan Securities believes that the CXO industry is gradually recovering from its low point, with many companies showing signs of recovery. This will be driven by factors such as interest rate cuts in the US, improved investment environments for pharmaceuticals, and policy support for innovation-driven industries. The company recommends focusing on related investment opportunities.
2. Infant Care Concepts Rise
As of the close, Jin Xin Life Sciences (01951) fell 4.17%, to HK$3.22; H&H International Holdings (01112) fell 2.09%, to HK$11.22; and Ausyuan (01717) rose 3.67%, to HK$2.54.
The government announced on July 28 that it would implement a new infant care support system, with a one-time subsidy of RMB3600 per child for children born before January 1, 2025, and not yet three years old. The policy is expected to benefit baby products and maternal care services.
3. Solar Stocks Recover
As of the close, Xinxin Technology (03800) rose 7.69%, to HK$1.26; Freetech Group (06865) rose 4.47%, to HK$11.22; and New Energy Holdings (01799) rose 4.4%, to HK$7.35.
The National Development and Reform Commission held a meeting on July 28, highlighting the need for comprehensive regulation of new energy vehicles and related industries. The commission also emphasized the importance of standardizing the development of solar energy and other key industries.